Answers are grounded in this paper and cite their sources.
Comparative analysis reveals phytoprobiotic therapy enhances clinical outcomes in calves with diarrhea, suggesting benefits for farm management.
The aim of the study is to conduct a comparative analysis of clinical and some immuno-biochemical parameters when using a complex phytoprobiotic agent to treat diarrhea in calves. For the experiment, two groups of newborn calves with signs of diarrhea were formed on a farm in the Zabaikalsky Region, with 10 animals in each (n = 20). From the second day of life, the calves of the experimental group were given the developed phytoprobiotic agent in the form of a solution, which included: bergenia radix root, rose hips (Surrexit coxis), chamomile flower decoction (Pyrethri flores), eleutherococcus rhizome (Rhizomede Siberian ginseng), and the probiotic Bacillus subtillis VKPM B-10641 at a dose of 1.5 ml/kg of live weight twice a day at 12-hour intervals; The control group of animals was given a solution of Bacillus subtillis VKPM B-10641 of at least 1 · 106 CFU of live bacterial spores at a dose of 3 ml/kg once a day for 10 days. Using generally accepted methods of clinical and laboratory analysis, the calves of the experimental group after 10 days of therapy recorded: normalization of clinical and hematological parameters, an increase in the level of total protein by 32.6%, an increase in albumin by 5.4 %. In animals of the control group, probably as a result of dehydration of the body, the albumin level was reduced by 4.2 %. An increase in globulins in the blood serum of young animals was observed by 12.8 and 14.7%, respectively (P ˂ 0.05). The albumin-globulin ratio in the experimental group corresponded to the normal background (1.0-1.2 units). Bactericidal and lysozyme activity of blood serum increased by 8.5 and 36.6 %, respectively (P ˂ 0.01). The complex phytoprobiotic can be recommended for oral therapy both for newborn calves and in their post-milk period as an astringent, anti-inflammatory and increasing non-specific resistance of the body agent, thereby reducing the use of synthetic drugs.
No takes yet. Share an insight, caveat, or question.
Lyubov' Savel'eva (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: